BackBrainstorm Cell Therapeutics Overview

Brainstorm Cell Therapeutics Other Income Expense Net

Brainstorm Cell Therapeutics other income & expense — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Other Income/Expense

$0.00

As of Jun 30, 2026

Annual Other Income/Expense (TTM)

$105000.00
76.72% YoY

Trailing 12 months ending Jun 30, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Brainstorm Cell Therapeutics (BCLI) FAQ

Stockcircle tracks other income & expense for Brainstorm Cell Therapeutics (BCLI), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Other Income & Expense page is built for Brainstorm Cell Therapeutics's historical other income/expense trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use other income/expense as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main BCLI overview so you can move from this figure to the surrounding analysis quickly.